Stock CTSO CYTOSORBENTS CORPORATION
Add to a list
To use this feature you must be a member
Log inSign up

News Cytosorbents Corporation

Equities

CTSO

US23283X2062

Real-time Estimate Cboe BZX
Other stock markets
 12:25:48 2024-07-03 pm EDT 		5-day change 1st Jan Change
0.855 USD +4.04% Intraday chart for Cytosorbents Corporation +4.64% -26.47%
Jun. 28 Cytosorbents Corporation announced that it expects to receive $20 million in funding CI
Jun. 24 CytoSorbents' Blood Purification Device Gets Approval in Taiwan MT

Summary

Search
See the results
Unlock all the news: Be the first to know and act before the market!
100% Free Registration
CytoSorbents Secures $20 Million Credit Facility
GL
Cytosorbents Corporation announced that it expects to receive $20 million in funding
CI
CytoSorbents' Blood Purification Device Gets Approval in Taiwan
MT
CytoSorbents Announces Regulatory Approval of CytoSorb® in Taiwan
GL
CytoSorbents Corporation Announces Regulatory Approval of CytoSorb® in Taiwan
CI
CytoSorbents Announces the Launch and Immediate Availability of the PuriFi™ Blood Pump in the European Union
GL
Cytosorbents Corporation Announces the Launch and Immediate Availability of the PuriFi Blood Pump in the European Union
CI
CytoSorbents to Host its 2024 Virtual Annual Stockholders Meeting
GL
CytoSorbents STAR Registry Data on Patients on Ticagrelor Undergoing CABG Surgery with CytoSorb Presented at EuroPCR 2024. Named Top Five Finalist for Best Scientific Abstract
GL
Earnings Flash (CTSO) CYTOSORBENTS Posts Q1 Revenue $9.8M, vs. Street Est of $9.79M
MT
Transcript : Cytosorbents Corporation, Q1 2024 Earnings Call, May 09, 2024
CytoSorbents: Q1 Earnings Snapshot
AQ
CytoSorbents Reports First Quarter 2024 Results
GL
Cytosorbents Corporation Reports Earnings Results for the First Quarter Ended March 31, 2024
CI
Transcript : Cytosorbents Corporation - Analyst/Investor Day
CytoSorbents May 6, 2024 Virtual KOL and Analyst-Investor Day: STAR-T Pivotal Trial Topline Results & Real World Experience with Antithrombotic Drug Removal in Europe
GL
CytoSorbents to Report First Quarter 2024 Operating and Financial Results
GL
STAR-T Pivotal Trial Results to Be Featured as a Late-Breaking Presentation at the 2024 American Association for Thoracic Surgery Annual Meeting
GL
Cytosorbents Corporation Reports Earnings Results for the Full Year Ended December 31, 2023
CI
Earnings Flash (CTSO) CYTOSORBENTS Reports Q4 Revenue $8.7M, vs. Street Est of $9.8M
MT
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. CTSO Stock
  4. News Cytosorbents Corporation